HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xingjian Liu Selected Research

Desmosine

1/2021A 28-day clinical trial of aerosolized hyaluronan in alpha-1 antiprotease deficiency COPD using desmosine as a surrogate marker for drug efficacy.
12/2018Free Desmosine is a Sensitive Marker of Smoke-Induced Emphysema.
1/2017The Pattern of Elastic Fiber Breakdown in Bleomycin-Induced Pulmonary Fibrosis May Reflect Microarchitectural Changes.
6/2015The Ratio of Free to Bound Desmosine and Isodesmosine May Reflect Emphysematous Changes in COPD.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xingjian Liu Research Topics

Disease

4Chronic Obstructive Pulmonary Disease (COPD)
07/2022 - 06/2015
4Lung Injury
12/2018 - 10/2014
4Pneumonia (Pneumonitis)
01/2018 - 12/2008
3Infections
01/2022 - 03/2020
3Pulmonary Emphysema
01/2021 - 01/2017
3Emphysema
12/2018 - 06/2015
3Pulmonary Fibrosis (Fibrosing Alveolitis)
01/2018 - 01/2017
2Acute Lung Injury
01/2017 - 10/2014
1Influenza in Birds (Avian Flu)
01/2022
1Fatigue
10/2020
1Stress Fractures (Stress Fracture)
10/2020
1Virus Diseases (Viral Diseases)
01/2019
1Lung Diseases (Lung Disease)
06/2015

Drug/Important Bio-Agent (IBA)

5ElastinIBA
07/2022 - 06/2015
4IsodesmosineIBA
01/2021 - 06/2015
4DesmosineIBA
01/2021 - 06/2015
3Biomarkers (Surrogate Marker)IBA
01/2021 - 06/2015
3Endothelin Receptor AntagonistsIBA
01/2018 - 10/2014
33- (3- carboxybenzyl)- 1- ((6- ethylbenzo(d)(1,3)dioxol- 5- yl)methyl)- 6- hydroxy- 4- oxo- 1,4- dihydroquinoline- 2- carboxylic acidIBA
01/2018 - 10/2014
3Endothelin-1 (Endothelin 1)IBA
01/2018 - 12/2008
2SmokeIBA
12/2018 - 12/2008
2Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
01/2018 - 01/2017
2Becaplermin (PDGF-BB)FDA Link
01/2018 - 01/2017
2CollagenIBA
01/2018 - 01/2017
2Chemokine CXCL12IBA
01/2018 - 01/2017
2Bleomycin (Blenoxane)FDA LinkGeneric
01/2017 - 01/2017
2LipopolysaccharidesIBA
01/2017 - 10/2014
2indium-bleomycinIBA
01/2017 - 01/2017
2Pancreatic Elastase (Elastase)IBA
01/2017 - 06/2015
2Peptides (Polypeptides)IBA
01/2017 - 06/2015
2Muramidase (Lysozyme)IBA
11/2011 - 03/2010
1Interferon-gamma (Interferon, gamma)IBA
01/2022
1Biological ProductsIBA
01/2022
1RNA (Ribonucleic Acid)IBA
01/2022
1Protease Inhibitors (Protease Inhibitor)IBA
01/2021
1Pharmaceutical PreparationsIBA
01/2021
1Hyaluronic Acid (Hyaluronan)IBA
01/2021
1GraphiteIBA
10/2020
1PolymersIBA
10/2020
1Antiviral Agents (Antivirals)IBA
03/2020
1InterferonsIBA
01/2019
1CytokinesIBA
01/2019
1Transforming Growth Factors (Transforming Growth Factor)IBA
01/2018
1Amiodarone (Amiodarona)FDA LinkGeneric
01/2018
1Type I Tumor Necrosis Factor ReceptorsIBA
01/2017
1Transforming Growth Factor beta (TGF-beta)IBA
01/2017
1EnzymesIBA
06/2015
1Tobramycin (Nebcin)FDA LinkGeneric
11/2011
1Anti-Bacterial Agents (Antibiotics)IBA
03/2010